Corcept Therapeutics

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
352
Market Cap
$3.6B
Website

An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression

Phase 3
Completed
Conditions
Interventions
First Posted Date
2005-09-07
Last Posted Date
2012-02-15
Lead Sponsor
Corcept Therapeutics
Target Recruit Count
247
Registration Number
NCT00146523
Locations
๐Ÿ‡ญ๐Ÿ‡ท

Dubravka Kocijan-Hercigonja M.D., Zagreb, Croatia

๐Ÿ‡ญ๐Ÿ‡ท

Vera Folnegovic-Smalc M.D./Ph.D., Zagreb, Croatia

๐Ÿ‡ท๐Ÿ‡ด

Mihai Dumitru Gheorge, Bucharest, Romania

and more 16 locations

A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression

First Posted Date
2005-08-16
Last Posted Date
2012-02-15
Lead Sponsor
Corcept Therapeutics
Target Recruit Count
257
Registration Number
NCT00130676
Locations
๐Ÿ‡บ๐Ÿ‡ธ

NMDNJ, Newark, New Jersey, United States

๐Ÿ‡บ๐Ÿ‡ธ

CNRI-LA, Pico Rivera, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Neurobehavioral Research Company, Lawrence, New York, United States

and more 19 locations

An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression

First Posted Date
2005-08-10
Last Posted Date
2012-02-15
Lead Sponsor
Corcept Therapeutics
Target Recruit Count
104
Registration Number
NCT00128505
Locations
๐Ÿ‡ง๐Ÿ‡ฌ

Svetlozar H Haralanov Ph.D., Sofia, Bulgaria

๐Ÿ‡ญ๐Ÿ‡ท

Vera Folnegovic-Smalc M.D/Ph.D, Zagreb, Croatia

๐Ÿ‡ง๐Ÿ‡ฌ

Vihra Milanova M.D., Sofia, Bulgaria

and more 16 locations

A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression

First Posted Date
2005-08-10
Last Posted Date
2012-02-15
Lead Sponsor
Corcept Therapeutics
Target Recruit Count
443
Registration Number
NCT00128479
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Saint Vincent Catholic Medical Centers of New York, Staten Island, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

CNS Research Institute (CRI), Philadelphia, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

Harmony Research, Johnson City, Tennessee, United States

and more 41 locations

Mifepristone as Adjunctive Therapy in Alzheimer's Disease

Phase 2
Terminated
Conditions
First Posted Date
2005-03-07
Last Posted Date
2009-12-11
Lead Sponsor
Corcept Therapeutics
Target Recruit Count
160
Registration Number
NCT00105105
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Clinical Trials Research Services, Pittsburgh, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

Clinical Physiology Associates, Ft. Myers, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

International Clinical Research Associates, Virginia Beach, Virginia, United States

and more 14 locations
ยฉ Copyright 2024. All Rights Reserved by MedPath